Tolerability and efficacy of almotriptan in the long-term treatment of migraine

European Neurology

Volumn 45, Issue 4, 2001, Pages 206-213

  Pascual, J ^a   Falk, R ^c   Docekal, R ^d   Prusinski, A ^e   Jelencsik, J ^f   Cabarrocas, X ^b   Segarra, X ^b   Luria, X ^b   Ferrer, P ^b  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b Almirall Prodesfarma ^*  (Spain)

^c Klinika Neurologie Vseobecna ^*

^d Medical Academy Hospital   (Czech Republic)

^e MEDICAL UNIVERSITY OF LODZ   (Poland)

^f SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Almotriptan; Long term; Migraine

Indexed keywords

ALMOTRIPTAN; SEROTONIN 1B AGONIST; SEROTONIN 1D AGONIST;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MIGRAINE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; SYNCOPE; THORAX PAIN; TREATMENT OUTCOME;

EID: 0034995238     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052131     Document Type: Article

References (24)

1. Migraine prevalence. A review of population-based studies
2. Prevalence and impact of migraine
3. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors
4. Symptomatic and nonsymptomatic headaches in a general population
5. Mode of action of the anti-migraine drug sumatriptan
6. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine
7. Serotonin receptors and the acute attack of migraine
8. Serotonin inhibits trigeminal nucleus activity evoked by craniovascular stimulation through a 5HT1B/1D receptor: A central action in migraine
9. Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the acute treatment of migraine and cluster headaches
10. Sumatriptan. An updated review of its use in migraine
11. Pharmacological profile of almotriptan, a novel antimigraine agent (poster)
12. Almotriptan
13. Therapy with other triptans: Almotriptan
14. Consistent efficacy and tolerability of almotriptan in the acute treatment of multiple migraine attacks: Results of a large, randomized, double-blind, placebo-controlled study
15. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain
16. Efficacy and safety of rizatriptan versus standard care during long-term treatment for migraine
17. The long-term tolerability and efficacy of oral zolmitriptan (Zomig, 311C90) in the acute treatment of migraine. An international study
18. Long-term experience with sumatriptan in the treatment of migraine
19. Tolerability and efficacy of naratriptan tablets with long-term treatment (6 months)
20. Tolerability profile of zolmitriptan (Zomig; 311C90), a novel dual central and peripherally acting 5HT1B/1D agonist. International clinical experience based on >3,000 subjects treated with zolmitriptan
21. Naratriptan is effective and well tolerated in the acute treatment of migraine. Results of a double-blind, placebo-controlled, parallel-group study
22. A placebo-controlled crossover study of rizatriptan in the treatment of multiple migraine attacks
23. Clinical efficacy and tolerability of 2.5 mg zolmitriptan for the acute treatment of migraine
24. Cardiovascular safety of 5HT1B/1D agonists - Is there a cause for concern?